MoneyWorks4Me

Aurobindo Pharma informs about completion of acquisition

15 Dec 2023 Evaluate

With reference to earlier letters dated July 3, 2023 and September 12, 2023 informing about acquisition of certain marketing and manufacturing related authorisations, Aurobindo Pharma has informed that the aforementioned acquisition has been completed on December 15, 2023. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..